Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.91B |
| 2 |
United Parcel Service
UPS
|
+$1.86B |
| 3 |
Chevron
CVX
|
+$1.72B |
| 4 |
Blackstone
BX
|
+$904M |
| 5 |
Ford
F
|
+$722M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$1.64B |
| 2 |
Prudential Financial
PRU
|
+$553M |
| 3 |
Genuine Parts
GPC
|
+$543M |
| 4 |
Cummins
CMI
|
+$538M |
| 5 |
Hartford Financial Services
HIG
|
+$376M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.33% |
| 2 | Healthcare | 13.03% |
| 3 | Financials | 11.86% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Industrials | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
RCI Hospitality Holdings
RICK
$194M
| $1.81M | ﹤0.01% |
23,198
+597
| +3% | +$51.8K |
|
2552
Hippo Holdings
HIPO
$876M
| $1.8M | ﹤0.01% |
110,682
+2,216
| +2% | +$36.2K |
|
2553
Qiagen
QGEN
$8.7B
| $1.79M | ﹤0.01% |
36,777
-22,401
| -38% | -$1.14M |
|
2554
SIGA Technologies
SIGA
$235M
| $1.79M | ﹤0.01% |
311,278
+2,563
| +0.8% | +$17.1K |
|
|
SGMO
2555
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.78M | ﹤0.01% |
1,013,774
-618
| -0.1% | -$1.76K |
|
|
NXDT
2556
NexPoint Diversified Real Estate Trust
NXDT
$237M
| $1.77M | ﹤0.01% |
170,954
+3,292
| +2% | +$39K |
|
|
HAYN
2557
DELISTED
Haynes International, Inc.
HAYN
| $1.77M | ﹤0.01% |
35,258
+1,013
| +3% | +$53.2K |
|
2558
Atea Pharmaceuticals
AVIR
$374M
| $1.76M | ﹤0.01% |
526,349
-38,145
| -7% | -$155K |
|
|
LICY
2559
DELISTED
Li-Cycle Holdings Corp.
LICY
| $1.76M | ﹤0.01% |
39,103
+709
| +2% | +$31.3K |
|
2560
Futu Holdings
FUTU
$15.3B
| $1.75M | ﹤0.01% |
33,779
+352
| +1% | +$17.1K |
|
2561
Tarsus Pharmaceuticals
TARS
$2.66B
| $1.75M | ﹤0.01% |
139,151
+600
| +0.4% | +$8.78K |
|
2562
Monte Rosa Therapeutics
GLUE
$1.35B
| $1.75M | ﹤0.01% |
224,386
-98
| -0% | -$681 |
|
|
ZYXI
2563
DELISTED
Zynex
ZYXI
| $1.73M | ﹤0.01% |
144,123
-33,399
| -19% | -$436K |
|
|
STKL
2564
DELISTED
SunOpta
STKL
| $1.71M | ﹤0.01% |
222,699
+2,948
| +1% | +$23.6K |
|
2565
Xponential Fitness
XPOF
$279M
| $1.71M | ﹤0.01% |
56,349
+9,196
| +20% | +$243K |
|
2566
Evolv Technologies
EVLV
$1.08B
| $1.71M | ﹤0.01% |
548,317
-22,070
| -4% | -$63K |
|
2567
Transcat
TRNS
$862M
| $1.71M | ﹤0.01% |
19,122
+211
| +1% | +$18K |
|
|
HLVX
2568
DELISTED
HilleVax
HLVX
| $1.7M | ﹤0.01% |
102,841
-259
| -0.3% | -$4.14K |
|
|
PNT
2569
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $1.69M | ﹤0.01% |
232,073
+11,569
| +5% | +$85.8K |
|
2570
Organogenesis Holdings
ORGO
$309M
| $1.68M | ﹤0.01% |
789,153
+1,092
| +0.1% | +$2.7K |
|
2571
Ouster
OUST
$3.2B
| $1.68M | ﹤0.01% |
200,812
+115,996
| +137% | +$1.35M |
|
2572
Lexicon Pharmaceuticals
LXRX
$1.09B
| $1.67M | ﹤0.01% |
688,611
-7,329
| -1% | -$16.8K |
|
2573
Erasca
ERAS
$6.48B
| $1.65M | ﹤0.01% |
549,088
+95,082
| +21% | +$346K |
|
|
TVRD
2574
Tvardi Therapeutics
TVRD
$18.9M
| $1.65M | ﹤0.01% |
9,330
-34
| -0.4% | -$11.4K |
|
2575
Tyra Biosciences
TYRA
$1.94B
| $1.65M | ﹤0.01% |
102,370
+3,867
| +4% | +$46K |
|
Similar funds
Charles Schwab's Q1 2023 Portfolio in Review
As of Q1 2023, Charles Schwab held 3,654 positions worth $329B, up 6% from $310B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q1 2023 filing shows 108 new, 2,088 increased, 988 reduced and 104 closed positions. Its largest new stake was GE HealthCare: 1,875,333 shares worth $154M. The largest sale was IBM, an estimated $1.64B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q1 2023 buy was GE HealthCare: 1,875,333 shares worth $154M.
- Charles Schwab added most to AbbVie in Q1 2023, an estimated $1.91B increase.
- Charles Schwab's biggest Q1 2023 reduction was IBM, cutting an estimated $1.64B.
- Charles Schwab fully exited STORE Capital Corporation in Q1 2023, selling an estimated $100M.
- Charles Schwab's ten largest holdings make up 17% of its $329B portfolio in Q1 2023.
- Charles Schwab opened 108 new positions and closed 104 in Q1 2023.
- Charles Schwab's portfolio value rose 6% quarter-over-quarter to $329B.
Based on Charles Schwab's 13F filing for Q1 2023, filed 12 May 2023.